Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 11, 1996, Pages 876-879

  Vu Thien, H ^a   Moissenet, D ^a   Valcin, M ^a   Dulot, C ^a   Tournier, G ^a   Garbarg Chenon, A ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCALIGENES; ARTICLE; BACTERIAL GENETICS; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

EID: 0029750266     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691221     Document Type: Article

References (13)

1. Steinbach S, Sun L, Jiang RZ, Flume R Gilligan P, Egan TM, Goldstein R: Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. New England Journal of Medicine 1994, 331: 981-987.
2. Lipuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL: Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990, 336: 1094-1096.
3. Govan JRW, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AR Webb AK: Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342: 15-19.
4. Klinger JD, Thomassen MJ: Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagnostic Microbiology and Infectious Disease 1985, 3: 149-158.
5. Valcin M, Moissenet D, Sardet A, Tournier G, Garbarg-Chenon A, Vu-Thien H: Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: epidemiological investigation by analysis of restriction fragment length polymorphism. Pathologie Biologie 1996, 44: 442-446.
6. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 1995, 33: 2233-2239.
7. Lipuma JJ, Mortensen JE, Dasen SE, Edlind TD, Schidlow DV, Burns JL, Stull TL: Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. Journal of Pediatrics 1988, 113: 859-862.
8. Fisher MC, Lipuma JJ, Dasen SE, Caputo GC, Mortensen JE, McGowan KE, Stull TL: Source of Pseudomonas cepacia: ribotyping of isolates from patients and from the environment. Journal of Pediatrics 1993, 123: 745-747.
9. Larsen GY, Stull TL, Burns JL: Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. Journal of Clinical Microbiology 1993, 31: 788-792.
10. Bingen E, Weber M, Derelle J, Brahimi N, Lambert-Zechovsky N, Vidailhet M, Navarro J, Elion J: Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. Journal of Clinical Microbiology 1993, 31: 2589-2593.
11. Dunne WM Jr, Maisch S: Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction. Clinical Infectious Diseases 1995, 20: 836-841.
12. Cheron M, Abachin E, Guerot E, El-Bez M, Simonet M: Investigation of hospital-acquired infections due to Alcaligenes denitrificans subsp. xylosoxidans by DNA restriction fragment length polymorphism. Journal of Clinical Microbiology 1994, 32: 1023-1026.
13. Mortensen JE, Fisher MC, Lipuma JJ: Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infection Control and Hospital Epidemiology 1995, 16: 30-32.